Search
UTSW study: RNA exosome key for B cell development: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/rna-exosome-key.html
New research from UT Southwestern suggests that RNA exosomes– the cellular machines that degrade old molecules of RNA – play a key role in the development of B cells, which are critical to the immune system’s ability to protect against infection.
UT Southwestern study defines anemia in pregnancy using uncomplicated U.S. cases: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/anemia-in-pregnancy.html
Maternal anemia has the same definition across the sociodemographic spectrum, according to a UT Southwestern study of a diverse population of uncomplicated patients.
Surveillance pathway tells cells when they run low on lipids: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/low-on-lipids.html
UT Southwestern researchers have discovered a molecular pathway that allows cells to sense when their lipid supplies become depleted, prompting a flurry of activity that prevents starvation. The findings, reported in Nature, might someday lead to new ways to combat metabolic disorders and a variety of other health conditions.
Promising compound kills range of hard-to-treat cancers by targeting a previously undiscovered vulnerability: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/hard-to-treat-cancers.html
A compound synthesized by a team led by UT Southwestern scientists kills a range of hard-to-treat cancer types by targeting a previously unexploited vulnerability, a new study reports.
Protecting your eyes from the summer sun: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/health-tips-ophthalmology.html
With summer approaching and temperatures on the rise, it’s important to protect not just your skin but also your eyes from the sun’s rays.
UTSW orthopedic surgeon honored for his work on diabetic limb salvage: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/diabetic-limb-salvage.html
Hip and knee replacements, sports injuries, trauma. That’s typically what comes to mind when one thinks of orthopedic surgery, not diabetes.
Breaking the shield that protects pancreatic cancer from immunotherapy: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/pancreatic-cancer-immunotherapy.html
Scar-like cells that make up a sizable portion of malignant pancreatic tumors and shield these cancers from immune attack are derived from mesothelial cells that line tissues and organs, a new study led by UT Southwestern researchers suggests.
Radiofrequency ablation offers a nonsurgical treatment for thyroid nodules: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/thyroid-nodules.html
When Vickie Bell-Percival was offered the opportunity to have a nodule on her thyroid treated with a new nonsurgical technique called radiofrequency ablation (RFA), she didn’t hesitate.
$25 million gift from Once Upon a Time Foundation establishes Raynor Cerebellum Project at UT Southwestern to tackle cerebellar dysfunction and disorders: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/raynor-cerebellum-project.html
A generous $25 million commitment from the Once Upon a Time Foundation will create the Raynor Cerebellum Project at UT Southwestern Medical Center (RCP-UTSW) to investigate diseases associated with cerebellum dysfunction, with the goal of discovering how to preserve and restore lost brain function.
UTSW researchers develop microbubble technology to enhance cancer immunotherapy : Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/microbubble-technology.html
Researchers at UT Southwestern have developed a first-of-its-kind ultrasound-guided cancer immunotherapy platform that delivers immune-stimulating agents to cells for the development of systemic anti-tumor immunity.